Stockscreener 앱 받기
23.97
1.20%
-0.29
전일 마감가:
$24.26
열려 있는:
$23.93
하루 거래량:
736.72K
Relative Volume:
0.85
시가총액:
$1.37B
수익:
$2.19B
순이익/손실:
$-829.17M
주가수익비율:
-1.6821
EPS:
-14.25
순현금흐름:
$-3.95M
1주 성능:
-19.24%
1개월 성능:
-8.06%
6개월 성능:
-21.51%
1년 성능:
-47.28%
1일 변동 폭
$23.88
$24.81
1주일 범위
$23.58
$29.89
52주 변동 폭
$23.58
$49.38
Enovis Corp Stock (ENOV) Company Profile
명칭
Enovis Corp
전화
(302) 252-9160
주소
2711 CENTERVILLE ROAD, WILMINGTON
ENOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
23.97 | 1.39B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 개시 | BTIG Research | Buy |
| 2024-10-03 | 개시 | JMP Securities | Mkt Outperform |
| 2024-06-13 | 개시 | JP Morgan | Neutral |
| 2024-02-13 | 개시 | Stephens | Overweight |
| 2024-01-22 | 개시 | UBS | Buy |
| 2024-01-03 | 개시 | William Blair | Outperform |
| 2023-12-15 | 재확인 | Needham | Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-06-26 | 개시 | Needham | Buy |
| 2023-05-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-11 | 개시 | Goldman | Buy |
| 2022-09-12 | 개시 | Canaccord Genuity | Buy |
| 2022-09-12 | 개시 | Evercore ISI | Outperform |
| 2022-06-28 | 개시 | Argus | Hold |
| 2022-06-27 | 재개 | Loop Capital | Buy |
| 2022-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Enovis Corp 주식(ENOV)의 최신 뉴스
Stock Market Recap: Is Enovis Corporation part of any ETFWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Support Test: Is HUBC stock showing strong momentumPortfolio Performance Summary & Weekly Breakout Watchlists - baoquankhu1.vn
March 20th Options Now Available For Enovis (ENOV) - Nasdaq
A Look At Enovis (ENOV) Valuation After Naming Oliver Engert As Chief Administrative Officer - Sahm
Enovis stock hits 52-week low at 25.43 USD By Investing.com - Investing.com Nigeria
Enovis Names Davide Visentin as President of International Surgical Division - MSN
Enovis (NYSE:ENOV) Hits New 1-Year LowTime to Sell? - MarketBeat
William Blair Maintains Enovis Corp(ENOV.US) With Buy Rating - 富途牛牛
Enovis stock hits 52-week low at 25.43 USD - Investing.com
Enovis (NYSE:ENOV) Releases FY 2025 Earnings Guidance - MarketBeat
Enovis Corporation (ENOV) Stock Analysis: Exploring the 68.66% Potential Upside for This Medical Device Innovator - DirectorsTalk Interviews
Enovis (NYSE:ENOV) Trading Down 7.3%Time to Sell? - MarketBeat
Enovis free cash flow set to improve in FY26, says Evercore ISI - TipRanks
How a Medical Device Company Uses Financial Instruments to Support Its Strategy - Citizens Bank
ENOV Earnings Expectations: Consensus Estimate Stands at $3.18 - GuruFocus
Enovis (ENOV) Surpasses EPS Expectations in Q4, Cash Flow Set to Improve - GuruFocus
Enovis (ENOV) Projects 50bps aEBITDA Expansion by 2026 - GuruFocus
Enovis Lowers Top End of 2025 Revenue Guidance - 富途牛牛
Enovis to Present at J.P. Morgan Healthcare Conference - TipRanks
Is Enovis (ENOV) Elevating Execution Risk Management With Its New Chief Administrative Officer? - simplywall.st
Will Enovis Corporation stock attract more institutional investors2025 Top Gainers & Risk Controlled Stock Alerts - Улправда
Why Enovis Corporation stock could see breakout soon2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда
Will Enovis Corporation stock outperform Nasdaq index2025 Earnings Impact & Real-Time Volume Analysis - ulpravda.ru
Why Enovis Corporation stock is in analyst buy zone2025 Bull vs Bear & Long-Term Safe Investment Ideas - Улправда
Is Enovis Corporation stock positioned for secular growthStop Loss & Reliable Volume Spike Alerts - Улправда
Why Enovis Corporation stock remains on watchlistsCEO Change & Community Consensus Picks - Улправда
Tributary Capital Management LLC Acquires 551,613 Shares of Enovis Corporation $ENOV - MarketBeat
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Enovis Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - Quiver Quantitative
Inside a medical tech company’s investor meetings at a health conference - Stock Titan
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at BTIG Research - MarketBeat
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Weakness - Yahoo Finance
Enovis initiated with a buy at BTIG - MSN
A Look At Enovis (ENOV) Valuation After Creating A New Chief Administrative Officer Role - simplywall.st
BTIG initiates Enovis stock with Buy rating, cites growth potential By Investing.com - Investing.com South Africa
BTIG Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $41 - 富途牛牛
Enovis price target lowered to $40 from $44 at Evercore ISI - MSN
BTIG Initiates Enovis at Buy With $41 Price Target - marketscreener.com
Enovis appoints McKinsey veteran Oliver Engert as chief administrative officer By Investing.com - Investing.com Nigeria
This Spire Global Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Benzinga
ENOV: BTIG Initiates Coverage with a "Buy" Rating and $41 PT | E - GuruFocus
BTIG initiates Enovis stock with Buy rating, cites growth potential - Investing.com
BTIG Initiates Coverage of Enovis (ENOV) with Buy Recommendation - Nasdaq
Enovis names Oliver Engert as CAO - Medical Buyer
Enovis Appoints Oliver Engert as Chief Administrative Officer - BioSpace
[Form 4] Enovis CORP Insider Trading Activity - Stock Titan
UBS Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Enovis appoints McKinsey veteran Oliver Engert as chief administrative officer - Investing.com
UBS lowers Enovis stock price target to $50 on updated estimates - Investing.com Canada
UBS lowers Enovis stock price target to $50 on updated estimates By Investing.com - Investing.com South Africa
About Us | Oil & Gas JournalEnovis Appoints Oliver Engert as Chief Administrative Officer - FinancialContent
Enovis Corp (ENOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):